Antibodies are blood proteins produced in response to and counteracting a specific antigen. Antibodies combine chemically with substances that the body recognizes as alien, such as bacteria, viruses, and foreign substances in the blood.
-
Date: June 01, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) The manufacturing process for cell and gene therapies is complex and can contain process-related impurities from multiple...
Date: May 31, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Introducing Nanostring’s latest spatial platform, CosMx Spatial Molecular Imager (SMI). Offering high-plex, multiomi...
Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. The ability to swiftly develop novel therapies often depends...
Date: May 17, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) Monoclonal antibody (mAb) is generated from a single clone of an antibody-producing cell and recognizes one specific epitop...
The Sarbecoviruses encodes a large panel of highly heterogeneous, but related zoonotic, epidemic and pandemic coronaviruses that include SARS-CoV and SARS-CoV2, which have been associated wit...
Date: April 26, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) C-C motif chemokine receptor-like 2 (CCRL2), is a non-signaling 7TM receptor, referred to as an atypical chemokine recep...
Date: April 21, 2022 Time: 8:00am (PDT), 11:00am (EDT), 6:00pm (CEST) Due to the low frequency of B cells in human peripheral blood, it can be difficult to obtain sufficient numbers of B cel...
Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. The ability to swiftly develop novel therapies often depends...
There is growing interest in the development of integrated continuous bioprocesses for the production of important biotherapeutics due to the potential for enhanced productivity, greater fle...
Biopharmaceuticals produced with mammalian cells are the key drivers for the medication of former untreatable diseases. The development of their production processes is still challenging bec...